Fortis Healthcare Sets November 5 Board Meeting for Q2 FY27

Fortis Healthcare Limited will consider its Q2 FY27 financial results on November 5, 2026, following Q1 FY27 revenue of ₹2,545 crore, up 17.46% year on year. The board meeting will review results for the quarter ended September 30, 2026, while a conference call with analysts and investors is scheduled for the following day.

When will Fortis Healthcare announce Q2 FY27 results?

Fortis Healthcare will hold its board meeting on Thursday, November 5, 2026, to consider and approve financial results for the period ended September 30, 2026, along with other business matters. The September quarter is the second quarter of India’s April-to-March financial year, and FY27 ends in March 2027.

The announced board meeting provides a formal date for the results consideration. Earlier material in the source had described November 14, 2026, as the statutory outer deadline for listed companies to publish September-quarter results within 45 days of the quarter end. That deadline was a regulatory limit, rather than an expected reporting date.

Fortis Healthcare has also announced a virtual investor meet on November 6, 2026, to discuss its unaudited Q2 FY27 and H1 FY27 financial results. The conference call is scheduled for 11:00 am IST and will allow analysts and investors to hear management’s discussion of quarterly performance and the operational outlook.

What did Fortis Healthcare report in Q1 FY27?

Fortis Healthcare reported Q1 FY27 revenue of ₹2,545 crore, representing sequential growth of 7.63% and year-on-year growth of 17.46%, according to the supplied financial summary. Gross profit was ₹415 crore, up 1.19% quarter on quarter and 6.69% year on year.

The same summary lists Q1 FY27 net profit at ₹268 crore, up 1.30% sequentially and 1.73% from a year earlier. Separate material in the supplied data cites Q1 FY27 net profit of ₹273 crore and describes it as 2.25% higher than ₹267 crore in Q1 FY26. The source therefore contains differing Q1 net-profit figures, while its revenue figure of ₹2,545 crore is consistent across the Q1 data presented.

The Q2 FY27 filing will cover July 1, 2026, to September 30, 2026. It is expected to include revenue, operating performance, net profit and notes to the accounts for the quarter, based on the scope described in the source material.

What is the comparison base for Fortis Healthcare's September quarter?

Fortis Healthcare reported revenue of ₹2,331 crore in Q2 FY26, the quarter ended September 2025. Net profit for that earlier September quarter was ₹329 crore, making these figures the reported year-on-year reference points for the forthcoming Q2 FY27 disclosure.

The company’s Q2 FY26 earnings call recorded consolidated revenue growth of 17.3% year on year. Its hospital business reported revenue of ₹1,974 crore, up 19.3%, while diagnostics net revenue was ₹357.5 crore, up 7.1%. The hospital business accounted for 85% of consolidated revenue in that quarter.

Consolidated operating EBITDA in Q2 FY26 was ₹556 crore, up 28% year on year, with the margin improving to 23.9% from 21.9%. Profit after tax before exceptional items rose 20.7% to ₹305 crore, according to the historical earnings-call material.

Which operating indicators matter for Fortis Healthcare investors?

Fortis Healthcare’s hospital occupancy, revenue per occupied bed and diagnostics performance are relevant operating measures alongside reported revenue and profit. In Q2 FY26, hospital occupancy improved to 71% from 69% in Q1 FY26, while occupied beds increased about 13% to 3,318.

The company reported a 5.8% increase in annualised revenue per occupied bed, or ARPOB, to ₹2.51 crore in Q2 FY26. Hospital operating EBITDA was ₹452 crore, and its margin improved by 150 basis points to 22.9%.

In diagnostics, gross revenue in Q2 FY26 rose 7.3% to ₹400 crore. The segment’s operating EBITDA margin was 26.1%, compared with 21.5% in the corresponding prior-year quarter. These historical metrics provide context for the mix of hospital and diagnostic operations investors may examine when Q2 FY27 numbers are released.

Why does the November results schedule matter to the market?

The November 5 board meeting gives investors a defined date for the release of Fortis Healthcare’s September-quarter financial information. It will be followed by the November 6 investor call, where management is scheduled to discuss Q2 FY27 and first-half FY27 unaudited results with analysts and investors.

No verified analyst estimate for Q2 FY27 revenue or profit is provided in the source material. As a result, the available factual comparison is between the reported Q2 FY26 base of ₹2,331 crore revenue and ₹329 crore net profit, and the company’s most recent reported Q1 FY27 revenue of ₹2,545 crore.

The results will also be relevant to investors tracking operating margins, the contribution from hospitals and diagnostics, and capacity-related commentary. Historical disclosures show that hospital occupancy and ARPOB were important drivers discussed alongside revenue and margins in the prior September-quarter call.

Conclusion

Fortis Healthcare has scheduled its Q2 FY27 results board meeting for November 5, 2026, with a management conference call set for November 6. The key disclosed financial reference is Q1 FY27 revenue of ₹2,545 crore, while the September-quarter comparison base is Q2 FY26 revenue of ₹2,331 crore and net profit of ₹329 crore.

Investors should watch for the approved Q2 FY27 financial statements, including revenue, profitability, operating margins and segment-level commentary. The November 6 call is the next disclosed event for management’s discussion of Q2 FY27 and H1 FY27 performance and outlook.